Ever since the abrupt disappearance of Pharmalot [January 1, 2014 gulp…], I’ve missed it every morning. I knew it was important, but I had no idea how important until it wasn’t there. Other blogs report the pharma stories [like Jack Friday at Pharmagossip], and I’m amazed that they’re so good at finding them. But nobody holds a candle to what Ed Silverman was able to do. Even though I was mainly interested in the ones that had to do with psychiatric drugs, I read most all of them and felt like that I knew about the industry as a whole. It was a rare moment that I ran across something that I didn’t read on Pharmalot first, or at the latest on the next day.
I expect most of us who have felt the loss of Pharmalot to keep up with things have had the same fantasy of finding some way that Ed could be independently supported to continue, but none of us have the required deep-pockets nor the right philanthropic connections. Rupert Murdoch, however, does:
Most of us were surprised, but Ed will still be Ed even with the WSJ. I look forward to seeing what he puts together there. Ed Silverman on the WSJ is better than no Ed Silverman at all. That’s for sure…
You can find Ed’s article “Brent Saunders, the CEO With $33 Billion Worth of Deals in 12 Months” at
http://blogs.wsj.com/corporate-intelligence/2014/02/18/